Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiocca

Showing results (611-620 of 728) with videos related to

Pageof 73
Sort By:
Head & Neck|November 2, 2021
Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16<sup>INK4a</sup> statusLaura Sichero, Marta Tagliabue, Giana Mota, et al.
Journal of Clinical Medicine|May 5, 2021
Association of Immune Thrombocytopenia and Inflammatory Bowel Disease in ChildrenAngela Guarina, Angelica Barone, Assunta Tornesello, et al.
AJNR. American Journal of Neuroradiology|February 19, 2004
Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]Michael H Lev, Yelda Ozsunar, John W Henson, et al.
Molecular Therapy Oncolytics|August 29, 2022
Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in gliomaMarilin S Koch, Mykola Zdioruk, Michal O Nowicki, et al.
Frontiers in Oncology|January 5, 2026
Quantifying TERT promoter mutations in tumor-derived DNA shed into the oral cavity as a potential biomarker for oral squamous cell carcinomaNoemy Starita, Marta Tagliabue, Tarik Gheit, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2022
STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma modelsGilles Berger, Erik H Knelson, Jorge L Jimenez-Macias, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2020
Correction: Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma TherapyCarmela Passaro, Quazim Alayo, Isabel DeLaura, et al.
Nature Communications|January 27, 2019
The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastomaVivek Bhaskaran, Michal O Nowicki, Mahmoud Idriss, et al.
Cancer Research|June 5, 2013
Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutationsRichard L Price, Jieun Song, Katherine Bingmer, et al.
Journal of Neurosurgery|July 11, 2025
Neurosurgical faculty and resident perspectives on collective bargaining efforts by resident physicians in the United StatesPrateek Agarwal, Mark M Zaki, Rohit Prem Kumar, et al.
Pageof 73

Showing results (611-620 of 728) with videos related to

Sort By:
Pageof 73
Head & Neck|November 2, 2021
Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16<sup>INK4a</sup> statusLaura Sichero, Marta Tagliabue, Giana Mota, et al.
Journal of Clinical Medicine|May 5, 2021
Association of Immune Thrombocytopenia and Inflammatory Bowel Disease in ChildrenAngela Guarina, Angelica Barone, Assunta Tornesello, et al.
AJNR. American Journal of Neuroradiology|February 19, 2004
Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]Michael H Lev, Yelda Ozsunar, John W Henson, et al.
Molecular Therapy Oncolytics|August 29, 2022
Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in gliomaMarilin S Koch, Mykola Zdioruk, Michal O Nowicki, et al.
Frontiers in Oncology|January 5, 2026
Quantifying TERT promoter mutations in tumor-derived DNA shed into the oral cavity as a potential biomarker for oral squamous cell carcinomaNoemy Starita, Marta Tagliabue, Tarik Gheit, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2022
STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma modelsGilles Berger, Erik H Knelson, Jorge L Jimenez-Macias, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2020
Correction: Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma TherapyCarmela Passaro, Quazim Alayo, Isabel DeLaura, et al.
Nature Communications|January 27, 2019
The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastomaVivek Bhaskaran, Michal O Nowicki, Mahmoud Idriss, et al.
Cancer Research|June 5, 2013
Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutationsRichard L Price, Jieun Song, Katherine Bingmer, et al.
Journal of Neurosurgery|July 11, 2025
Neurosurgical faculty and resident perspectives on collective bargaining efforts by resident physicians in the United StatesPrateek Agarwal, Mark M Zaki, Rohit Prem Kumar, et al.
Pageof 73